Drugs · acquisition-cost intelligence
Alavert Allergy
loratadine· ingredient loratadine· LORATADINE 10 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.51467
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other loratadine products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| basic care childrens allergy relief | $0.04072 | −$0.47390 |
| 24 / 7 Life Non-Drowsy Allergy Relief | $0.05293 | −$0.46170 |
| Basic Care Childrens Allergy Relief | $0.52258 | +$0.00790 |
| allergy congestion relief | $0.58514 | +$0.07050 |
| Alavert Allergy and Congestion D-12 hour | $0.80184 | +$0.28720 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.